ArticleCureus2022

A Comparison of Inhaled Epoprostenol in Patients With Acute Respiratory Distress Syndrome and COVID-19-Associated Acute Respiratory Distress Syndrome.

John Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.